ReviewBMJ global health2017
Antimicrobial resistance and universal health coverage.
Review in BMJ global health, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
56 citing papers in PubMed, 1 synthesis or guideline pooled it, 97 citations in OpenAlex.
- Improving antibiotic use through behaviour change: a systematic review of interventions evaluated in low- and middle-income countries.Health policy and planning · 2021Pooled it
- 'Responsive Dialogues', an engagement framework for antimicrobial resistance: a cross-country qualitative evaluation in Thailand and Malawi.Global health action · 2026Article
- Strengthening One Health Antimicrobial Resistance Surveillance in Bangladesh: Insights from the Fleming fund country grant.One health (Amsterdam, Netherlands) · 2026Review
- Landscape Analysis of Existing Policies, Laws and Regulations on Antimicrobial Stewardship in 10 Low- and Middle-Income Countries.Antibiotics (Basel, Switzerland) · 2026Article
- Mapping the landscape of mathematical models for antimicrobial resistance: a scoping review.BMC public health · 2026Article
- Climate change and antimicrobial resistance in the Western Pacific: a mixed-methods systematic analysis.The Lancet regional health. Western Pacific · 2026Article
- Leveraging a people-centred approach to combat antimicrobial resistance in Africa.Tropical medicine and health · 2025Review
- The impact of health and technology shifts on antibiotic use among the elderly in Thailand.Scientific reports · 2025Article
- Frontiers in superbug management: innovating approaches to combat antimicrobial resistance.Archives of microbiology · 2025Review
- Antibiotic dispensing behaviors for pediatric diarrhea: A qualitative study of informal healthcare providers in rural Bangladesh.PloS one · 2025Article
- Understanding the Determinants Influencing Self-Medication with Antibiotics Among Malaysian Residents: A Qualitative Study to Inform Preventive Public Health Strategies.Antibiotics (Basel, Switzerland) · 2024Article
- AMR and Sustainable Development Goals: at a crossroads.Globalization and health · 2024Review
- Antibiotic consumption in hospitals in humanitarian settings in Afghanistan, Bangladesh, Democratic Republic of Congo, Ethiopia and South Sudan.Antimicrobial resistance and infection control · 2024Article
- New Agents Are Coming, and So Is the Resistance.Antibiotics (Basel, Switzerland) · 2024Review
- Microplastics as carriers of antibiotic resistance genes and pathogens in municipal solid waste (MSW) landfill leachate and soil: a review.Journal of environmental health science & engineering · 2024Review
- The facilitators of and barriers to antimicrobial use and misuse in Lalitpur, Nepal: a qualitative study.BMC public health · 2024Article
- The crucial role of pharmacovigilance in managing infectious diseases in lower and middle-income countries.Therapeutic advances in drug safety · 2024Article
- Article
- A one health approach to tackling AMR and why gender matters: findings from pastoralist communities in Tanzania.Frontiers in global women's health · 2024Article
- Antimicrobial stewardship in private pharmacies in Wakiso district, Uganda: a qualitative study.Journal of pharmaceutical policy and practice · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 4 institutions in 4 countries.
Funding
Abstract
The WHO launched a Global Action Plan on antimicrobial resistance (AMR) in 2015. World leaders in the G7, G20 and the UN General Assembly have declared AMR to be a global crisis. World leaders have also adopted universal health coverage (UHC) as a key target under the sustainable development goals. This paper argues that neither initiative is likely to succeed in isolation from the other and that the policy goals should be to both provide access to appropriate antimicrobial treatment and reduce the risk of the emergence and spread of resistance by taking a systems approach. It focuses on outpatient treatment of human infections and identifies a number of interventions that would be needed to achieve these policy goals. It then shows how a strategy for achieving key attributes of a health system for UHC can take into account the need to address AMR as part of a UHC strategy in any country. It concludes with a list of recommended priority actions for integrating initiatives on AMR and UHC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.